Literature DB >> 26729021

Prevalence and correlates of diabetes mellitus in Uganda: a population-based national survey.

Silver Bahendeka1, Ronald Wesonga2, Gerald Mutungi3, James Muwonge4, Stella Neema5, David Guwatudde6.   

Abstract

OBJECTIVE: We analysed fasting blood glucose (FBG) and other data collected as part of a population-based nationwide non-communicable disease risk factor survey, to estimate the prevalence of impaired fasting glycaemia (IFG) and diabetes mellitus and to identify associated factors in Uganda.
METHODS: The nationwide cross-sectional survey was conducted between April and July 2014. Participants were adults aged 18-69 years. A multistage stratified sample design was used to produce a national representative sample. Fasting capillary glucose was measured to estimate glycaemia. Data were managed with WHO e-STEPs software and Epi Info. Stata(®) survey procedures were used to account for the sampling design, and sampling weights were used to account for differential probability of selection between strata.
RESULTS: Of the 3689 participants, 1467 (39.8%) were males, and 2713 (73.5%) resided in the rural areas. The mean age was 35.1 years (standard deviation = 12.6) for males and 35.8 years (13.2) for females. The overall prevalence of IFG was 2.0% (95% confidence interval (CI) = 1.5-2.5%), whereas that of diabetes mellitus was 1.4% (95% CI 0.9-1.9%). The prevalence of IFG was 2.1% (95% CI 1.3-2.9%) among males and 1.9% (95% CI 1.3-2.6%) among females, whereas that of diabetes mellitus was 1.6% (95% CI 0.8-2.6%) and 1.1% (95% CI 0.6-1.7%), respectively. The prevalence of IFG was 2.6% (95% CI 1.4-3.8%) among urban and 1.9% (95% CI 1.3-2.4%) among rural residents, whereas that of diabetes mellitus was 2.7% (95% CI 1.4-4.1) and 1.0% (95% 0.5-1.6%), respectively. The majority of participants identified with hyperglycaemia (90.5% IFG and 48.9% diabetes) were not aware of their hyperglycaemic status. Factors associated with IFG were region of residence, body mass index and total cholesterol; factors associated with diabetes mellitus were age, sex, household floor finish and abdominal obesity.
CONCLUSION: The prevalence of IFG and of diabetes mellitus is low in the Ugandan population, providing an opportunity for the prevention of diabetes. The majority of persons with hyperglycaemia were not aware of their hyperglycaemic status, which implies a likelihood of presenting late with complications.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Diabetes Mellitus; Ouganda; Uganda; Uganda.; chronic disease epidemiology; diabetes mellitus; diabète sucré; enfermedades no transmisibles; epidemiología de patologías crónicas; maladies non transmissibles; non-communicable diseases; épidémiologie des maladies chroniques

Mesh:

Substances:

Year:  2016        PMID: 26729021     DOI: 10.1111/tmi.12663

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  47 in total

Review 1.  Diabetes Among Non-Overweight Individuals: an Emerging Public Health Challenge.

Authors:  Unjali P Gujral; Mary Beth Weber; Lisa R Staimez; K M Venkat Narayan
Journal:  Curr Diab Rep       Date:  2018-07-04       Impact factor: 4.810

2.  The relationship between perceived social support from family and diabetes self-management among patients in Uganda.

Authors:  Jude Tadeo Onyango; Jane Frances Namatovu; Innocent Kabahena Besigye; Mark Kaddumukasa; Scovia Nalugo Mbalinda
Journal:  Pan Afr Med J       Date:  2022-04-07

3.  Vitamin D with Calcium Supplementation Managing Glycemic Control with HbA1c and Improve Quality of Life in Patients with Diabetes

Authors:  Sanjana Mehta; Parminder Nain; Bimal K Agrawal; Rajinder Pal Singh
Journal:  Turk J Pharm Sci       Date:  2022-04-29

4.  Burden of cumulative risk factors associated with non-communicable diseases among adults in Uganda: evidence from a national baseline survey.

Authors:  Ronald Wesonga; David Guwatudde; Silver K Bahendeka; Gerald Mutungi; Fabian Nabugoomu; James Muwonge
Journal:  Int J Equity Health       Date:  2016-12-01

5.  Exploring knowledge and attitudes toward non-communicable diseases among village health teams in Eastern Uganda: a cross-sectional study.

Authors:  Temitope Tabitha Ojo; Nicola L Hawley; Mayur M Desai; Ann R Akiteng; David Guwatudde; Jeremy I Schwartz
Journal:  BMC Public Health       Date:  2017-12-12       Impact factor: 3.295

6.  Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.

Authors:  Davis Kibirige; David Atuhe; Leaticia Kampiire; Daniel Ssekikubo Kiggundu; Pamela Donggo; Juliet Nabbaale; Raymond Mbayo Mwebaze; Robert Kalyesubula; William Lumu
Journal:  Int J Equity Health       Date:  2017-08-24

7.  Frequency and predictors of suboptimal glycemic control in an African diabetic population.

Authors:  Davis Kibirige; George Patrick Akabwai; Leaticia Kampiire; Daniel Ssekikubo Kiggundu; William Lumu
Journal:  Int J Gen Med       Date:  2017-02-20

8.  Kidney disease in Uganda: a community based study.

Authors:  Robert Kalyesubula; Joaniter I Nankabirwa; Isaac Ssinabulya; Trishul Siddharthan; James Kayima; Jane Nakibuuka; Robert A Salata; Charles Mondo; Moses R Kamya; Donald Hricik
Journal:  BMC Nephrol       Date:  2017-04-03       Impact factor: 2.388

9.  Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda.

Authors:  Faraja S Chiwanga; Marina A Njelekela; Megan B Diamond; Francis Bajunirwe; David Guwatudde; Joan Nankya-Mutyoba; Robert Kalyesubula; Clement Adebamowo; IkeOluwapo Ajayi; Todd G Reid; Jimmy Volmink; Carien Laurence; Hans-Olov Adami; Michelle D Holmes; Shona Dalal
Journal:  Glob Health Action       Date:  2016-05-23       Impact factor: 2.640

Review 10.  Built environmental characteristics and diabetes: a systematic review and meta-analysis.

Authors:  N R den Braver; J Lakerveld; F Rutters; L J Schoonmade; J Brug; J W J Beulens
Journal:  BMC Med       Date:  2018-01-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.